Implementation of a three-tiered approach to identify and characterize anti-drug antibodies raised against HIV-specific broadly neutralizing antibodies-Reference-Cited by-同舟云学术

Implementation of a three-tiered approach to identify and characterize anti-drug antibodies raised against HIV-specific broadly neutralizing antibodies

Published:2020-04 Issue: Volume:479 Page:112764
ISSN:0022-1759
Container-title:Journal of Immunological Methods
language:en
Short-container-title:Journal of Immunological Methods

Author:

Bharadwaj Pranay,Riekofski Cassidy,Lin Shu,Seaman Michael S.,Garber David A.,Montefiori David,Sarzotti-Kelsoe Marcella,Ackerman Margaret E.,Weiner Joshua A.

Funder

Bill and Melinda Gates Foundation

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference52 articles.

1. Increased rheumatoid factor interference observed during immunogenicity assessment of an fc-engineered therapeutic antibody;Araujo;J. Pharm. Biomed. Anal.,2011

2. A phase I trial with two human monoclonal antibodies (hMAb 2F5, 2G12) against HIV-1;Armbruster;Aids,2002

3. Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals;Bar-On;Nat. Med.,2018

4. A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals;Burton;Proc. Natl. Acad. Sci. U. S. A.,1991

5. Dilution protocols for detection of hook effects/prozone phenomenon;Butch;Clin. Chem.,2000

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and pharmacokinetics of VRC07-523LS administered via different routes and doses (HVTN 127/HPTN 087): A Phase I randomized clinical trial;PLOS Medicine;2024-06-24

2. Selection of positive controls and their impact on anti-drug antibody assay performance;Journal of Immunological Methods;2024-05

3. A Randomised Clinical Trial of the Safety and Pharmacokinetics of VRC07-523LS Administered via Different Routes and Doses (HVTN 127/HPTN 087);2024-01-11

4. Application of N-Terminal Site-Specific Biotin and Digoxigenin Conjugates to Clinical Anti-drug Antibody Assay Development;Bioconjugate Chemistry;2023-12-05

5. Adults on pre-exposure prophylaxis (tenofovir-emtricitabine) have faster clearance of anti-HIV monoclonal antibody VRC01;Nature Communications;2023-11-28